GNMSF GENMAB A/S

NEUTRAL Impact: 2/10 6-K
Horizon immediate Filed May 29, 2026 Processed 14d 17h ago SEC 0001434265-26-000085
Notable filing: 6-K
Latest settled — T+5d
GNMSF ▼ -0.83% at T+5d
NEUTRAL call ✗ call lost -0.83% · α vs SPY +1.92% · entry $251.55 → $249.45
Next anchor: T+20d in 16d
Currently $249.00 · -1.01% from $251.55 entry
Entry anchored
May 29, 2026
via day open
T+1d
-7.64%
call -7.64% · α -7.78%
$232.34
settled 12d ago
T+5d
-0.83%
call -0.83% · α +1.92%
$249.45
settled 8d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

This 6-K filing reports a routine insider sale by Board member Michael Kavanagh, who sold 526 shares at DKK 1,734.75 each on May 29, 2026. The transaction is small in size and does not convey material information about the company's operations or financial condition.

Actionable Insight

This is a routine insider disclosure with no trading signal. The small sale by a board member is likely for personal liquidity or tax planning. Monitor for any cluster of insider selling or larger transactions that could indicate a change in sentiment.

Key Facts

  • Board member Michael Kavanagh sold 526 shares at DKK 1,734.75 per share on May 29, 2026
  • Total proceeds from the sale were approximately DKK 912,000 (about $132,000)
  • The sale was executed on NASDAQ Copenhagen
  • No other material business developments were disclosed in this filing

Financial Impact

Insider sale of approximately $132,000 — immaterial relative to Genmab's market cap

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (27 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000085
Document: gmab_29052026x6k.htm0001434265-26-000085
Document: 0001434265-26-000085-index-headers.html0001434265-26-000085
Document: 0001434265-26-000085-index.html0001434265-26-000085
Document: 0001434265-26-000085.txt0001434265-26-000085
10 reports for GNMSF
Performance horizon
Filters
Rows
Reports for GNMSF — sortable, filterable
Type Now
May 29, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$251.55 $249.45▼ −0.83%▲ +1.92%$249.00 (−1.01%)
May 13, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$268.24 $265.27▼ −1.11%▲ +0.05%$249.00 (−7.17%)
May 12, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$264.64 $265.27▲ +0.24%▲ +0.16%$249.00 (−5.91%)
May 8, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$259.60 $265.27▲ +2.18%▲ +2.27%$249.00 (−4.08%)
Apr 17, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$281.75 $271.83▼ −3.52%▼ −4.08%$249.00 (−11.62%)
Apr 17, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$281.75 $271.83▼ −3.52%▼ −4.08%$249.00 (−11.62%)
Apr 14, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$273.25 $281.75▲ +3.11%▲ +1.72%$249.00 (−8.87%)
Apr 1, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$265.00 $298.38▲ +12.60%▲ +8.83%$249.00 (−6.04%)
Apr 1, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$265.00 $298.38▲ +12.60%▲ +8.83%$249.00 (−6.04%)
Mar 30, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$265.00 $281.06▲ +6.06%▲ +2.12%$249.00 (−6.04%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (46h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access